ArticleJournal of cardiovascular medicine (Hagerstown, Md.)2022

Rationale and design of the effects of EMpagliflozin on left ventricular DIAstolic function in diabetes (EmDia) study.

Claus Jünger et al.PubMed ↗Publisher ↗

No numbers read from the abstract.